The multifaced role of STAT3 in cancer and its implication for anticancer therapy

M Tolomeo, A Cascio - International journal of molecular sciences, 2021 - mdpi.com
Signal transducer and activator of transcription (STAT) 3 is one of the most complex
regulators of transcription. Constitutive activation of STAT3 has been reported in many types …

[HTML][HTML] Highlighted STAT3 as a potential drug target for cancer therapy

H Lee, AJ Jeong, SK Ye - BMB reports, 2019 - ncbi.nlm.nih.gov
Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription
factor that regulates cell proliferation, differentiation, apoptosis, angiogenesis, inflammation …

Strategies and approaches of targeting STAT3 for cancer treatment

SL Furtek, DS Backos, CJ Matheson… - ACS chemical …, 2016 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates the expression of genes related to cell cycle, cell survival, and immune response …

Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature

CD Mohan, S Rangappa, HD Preetham… - Seminars in cancer …, 2022 - Elsevier
Signal transducer and activator of transcription (STAT) proteins are latent transcription
factors that reside in the cytoplasm of several types of cells. In canonical signaling, upon …

Transcription factor STAT3 as a novel molecular target for cancer prevention

A Xiong, Z Yang, Y Shen, J Zhou, Q Shen - Cancers, 2014 - mdpi.com
Signal Transducers and Activators of Transcription (STATs) are a family of transcription
factors that regulate cell proliferation, differentiation, apoptosis, immune and inflammatory …

Oximes: Novel therapeutics with anticancer and anti-inflammatory potential

IA Schepetkin, MB Plotnikov, AI Khlebnikov… - Biomolecules, 2021 - mdpi.com
Oximes have been studied for decades because of their significant roles as
acetylcholinesterase reactivators. Over the last twenty years, a large number of oximes have …

[HTML][HTML] STAT3 signaling in ovarian cancer: a potential therapeutic target

R Liang, X Chen, L Chen, F Wan, K Chen, Y Sun… - Journal of …, 2020 - ncbi.nlm.nih.gov
Accumulating evidence has shown that Signal Transducer and Activator of Transcription 3
(STAT3) is thought to be a promising target for cancer therapy as STAT3 is frequently …

Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: mechanism and therapeutic opportunity

CJ Wu, V Sundararajan, BC Sheu, RYJ Huang, LH Wei - Cancers, 2019 - mdpi.com
Epithelial ovarian cancer (EOC) is the most lethal of all gynecologic malignancies. Despite
advances in surgical and chemotherapeutic options, most patients with advanced EOC have …

STAT3 transcription factor as target for anti-cancer therapy

AM Mohassab, HA Hassan, D Abdelhamid… - Pharmacological …, 2020 - Springer
STATs constitute a large family of transcription activators and transducers of signals that
have an important role in many cell functions as regulation of proliferation and differentiation …

Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related …

P Shen, Y Wang, X Jia, P Xu, L Qin, X Feng, Z Li… - European journal of …, 2022 - Elsevier
Janus kinases (JAKs) are the non-receptor tyrosine kinases covering JAK1, JAK2, JAK3,
and TYK2 which regulate signal transductions of hematopoietic cytokines and growth factors …